IL10 and neoplasm: Immune suppressive and tumor-promoting action of IL-10 was supported by finding that IL-10 deficiency enhanced the efficacy of DC-based immunotherapy, reduced MDSC and Treg levels in the TME, and promoted Th1-type antitumor responses in mice [70].